Related by context. All words. (Click for frequent words.) 71 REACH Registry 68 Skin Lesions 67 Patient Outcomes 67 Stent Thrombosis 66 Clinical Outcome 66 Bloodstream Infections 66 Hospitalized Patients 66 Lung Injury 65 Treating Chronic 65 Breast Cancer Recurrence 65 Dual Antiplatelet Therapy 65 Cardiovascular Outcomes 64 Fracture Risk 64 Fungal Infections 64 Acute Coronary Syndromes 64 Acute Myocardial 64 CABG Surgery 64 Acute Decompensated Heart Failure 64 Prospective Randomized 63 Minimally Invasive Treatment 63 Bone Mineral Density 63 Breast Density 63 Medication Errors 63 Recurrent Breast Cancer 63 Cardiovascular Disease Risk 63 Acute Myocardial Infarction 63 Rheumatoid Arthritis Patients 63 Cardiovascular Events 63 Carotid Stenting 63 Kidney Function 63 Surgical Procedures 63 Renal Cancer 63 Acute Heart Failure 63 Intracerebral Hemorrhage 63 Clinical Outcomes 63 Guidelines Issued 63 Acute Coronary Syndrome 63 Septic Shock 63 LDL Cholesterol 63 Preterm Delivery 62 Left Atrial 62 Statin Therapy 62 Clinical Trial Data 62 Oral Mucositis 62 Inflammatory Markers 62 Venous Thromboembolism 62 Fibromyalgia Pain 62 Invasive Fungal Infections 62 Chronic Bronchitis 62 Antibiotic Treatment 62 Cardiotoxicity 62 Drug Prevents 62 Long Term Survival 62 Surgical Treatment 62 Liver Failure 62 ST Segment Elevation 62 Heart Failure Patients 62 Localized Prostate Cancer 62 Catheter Associated 62 Inhaled Nitric Oxide 62 Blood Clot Risk 62 Vertebral Fractures 62 Diabetic Patients 62 Adjuvant Chemotherapy 62 Insulin Therapy 62 Outcomes Relevant 62 MRSA Infections 62 Critically Ill Patients 62 Iron Overload 62 Hypercholesterolemia 62 Randomized Controlled Trials 62 Coronary Disease 62 Quality Indicators 61 Symptom Relief 61 Overactive Bladder 61 Stress Incontinence 61 Lung Function 61 Appears Safe 61 atherothrombotic disease 61 Post Operative 61 Hyperlipidemia 61 Vitamin D Linked 61 Cognitive Impairment 61 Knee Osteoarthritis 61 See CLINICAL PHARMACOLOGY 61 Ischemic Stroke 61 Hemorrhagic Stroke 61 Decompensated Heart Failure 61 Antiplatelet Therapy 61 Coronary Artery Bypass Graft 61 Prostate Cancer Patients 61 Neoadjuvant Chemotherapy 61 Pulmonary Arterial Hypertension 61 Platelet Counts 61 Periodontal Disease 61 Renal Failure 61 Oral Fingolimod 61 Acute Ischemic Stroke 61 Hip Fractures 61 Adverse Event 61 Chronic Heart Failure 61 See ID nDEL# 61 Cholesterol Levels 61 Thromboembolism 61 Statin Drugs 61 CONSOLIDATED FINANCIAL SUMMARY 61 Obese Patients 61 Outpatient Setting 61 Salt Intake 61 Secondary Hyperparathyroidism 61 Insulin Sensitivity 61 Albuminuria 61 Hepatotoxicity 61 Hospital Acquired Pneumonia 60 Migraine Pain 60 Prostate Screening 60 Spinal Manipulation 60 Outcome Measures 60 Randomized Evaluation 60 Aortic Stenosis 60 Subgroup Analysis 60 Childhood Vaccinations 60 Calcium Intake 60 Proves Effective 60 See WARNINGS 60 Premenopausal Women 60 Infarct 60 Myocardial Ischemia 60 Demonstrates Positive 60 Uterine Fibroid Embolization 60 Unmet Need 60 Anticoagulation 60 Coronary Artery Calcium 60 Iron Deficiency 60 Infarction 60 intravascular hemolysis 60 Invasive Breast Cancer 60 Diabetic Neuropathy 60 Ischemic 60 Less Invasive 60 Bone Fractures 60 Gastric Cancer 60 Limb Ischemia 60 Serious Infections 60 Improve Outcomes 60 Respiratory Distress 60 Left Ventricular Hypertrophy 60 Hepatocellular Carcinoma 60 STRIDE PD 60 Combo Therapy 60 Inflammatory Diseases 60 ANN INTERN MED 60 Clinical Trial Results 60 Hormone Receptor Positive 60 Osteoarthritis Patients 60 Urinary Tract Infections 60 Blood Cancers 60 Patients Receiving 60 Glycemia 60 Severe Sepsis 60 Inhaled Steroids 60 Obese Teens 60 Chronic Hepatitis B 60 Advanced Melanoma 60 Urinary Incontinence 60 Treating Depression 60 Schizophrenia Treatment 60 Severe Asthma 60 Non Alcoholic Fatty 60 Improve Survival 60 Prognostic Value 59 Restenosis 59 Medication Adherence 59 DOWNEY FINANCIAL CORP. AND 59 CT Angiography 59 Prolongs Survival 59 Pregnancy Outcomes 59 Premature Births 59 Combination Treatment 59 Phase III Clinical Trial 59 Treatment Reduces 59 Recurrent Stroke 59 Glycemic Control 59 Beta Blockers 59 Paroxysmal 59 Catheter Ablation 59 Depressive Symptoms 59 Preterm Labor 59 Plaque Psoriasis 59 Pneumococcal Vaccine 59 Adult Stem Cell Therapy 59 Clinical Evaluation 59 Morbidity Mortality 59 Community Acquired Pneumonia 59 Antitumor Activity 59 Coronary Angiography 59 Multiple Myeloma Patients 59 Thrombotic 59 Respiratory Infections 59 Stem Cell Treatment 59 cytomegalovirus infection 59 Deep Venous Thrombosis 59 Prospective Multicenter 59 Demonstrates Potent 59 Readmissions 59 Prostate Cancer Treatment 59 Renal Insufficiency 59 Thromboembolic 59 Advanced Prostate Cancer 59 Randomized Clinical Trials 59 Arteriosclerosis 59 Microalbuminuria 59 Vitamin D Deficiency 59 Clinical Efficacy 59 ST Elevation Myocardial 59 Radiofrequency Ablation 59 Metastatic Prostate Cancer 59 Allergic Rhinitis 59 Fecal Incontinence 59 Aortic Dissection 59 HeFH 59 Laryngeal Cancer 59 Exacerbations 59 Orthostatic Hypotension 59 atherothrombosis 59 Clostridium difficile Infection 59 Tumor Response 59 Artery Disease 59 Visceral Fat 59 Demonstrates Significant 59 Pivotal Clinical Trial 59 Hip Fracture 59 Sleep Disturbances 59 Test Detects 59 Meta Analysis 59 Ranolazine 59 Portal Hypertension 59 Febrile Neutropenia 59 venous thromboembolic disease 59 Lung Cancer Trial 59 First Patient Enrolled 59 Increased Mortality 59 Preterm Birth 59 Sleep Disordered Breathing 59 Data Suggest 59 Adjuvant Therapy 59 Uterine Fibroids 59 Valsartan 59 Reduced Risk 59 Autoimmune Diseases 58 Lymphoma Patients 58 HCV Protease Inhibitor 58 Uterine Cancer 58 Juvenile Idiopathic Arthritis 58 Viral Infections 58 Renal Cell Carcinoma 58 Iron Deficiency Anemia 58 Medicare Reimbursement 58 atherogenic dyslipidemia 58 Arrhythmias 58 Guideline Update 58 Mitral Regurgitation 58 Valvular Heart Disease 58 Data Indicate 58 Knee Implant 58 Clinical Documentation 58 Severe Acne 58 Peritoneal Dialysis 58 Controlled Trial 58 Sleep Duration 58 Metabolic Disorder 58 Maven Semantic 58 Patient Satisfaction 58 Cardiovascular Risk Factors 58 Emerging Therapies 58 Pesticide Exposure 58 Colorectal Cancers 58 EHR Adoption 58 Intravenous Immunoglobulin 58 EuroIntervention 58 Levels Linked 58 Thrombolytic Therapy 58 Peripheral Vascular Disease 58 Node Negative 58 Genetic Variants 58 Genital Herpes 58 Metastatic Renal Cell Carcinoma 58 Phase 2b Trial 58 Nonalcoholic Fatty Liver Disease 58 Statin Use 58 Advanced Pancreatic Cancer 58 Asthma COPD 58 Prostate Cancer Screening 58 Computed Tomographic 58 Stent Placement 58 Genetic Tests 58 Brain Shrinkage 58 Hazardous Drugs 58 Malignant Pleural Mesothelioma 58 Hypotension 58 Phase 2b Clinical Trial 58 Vulnerable Plaque 58 CyberKnife Radiosurgery 58 Events MACE 58 Obesity Linked 58 Radiation Induced 58 Oral Anticoagulants 58 Chronic Sinusitis 58 #-# Full Text 58 Cervical Dysplasia 58 Lowers Risk 58 Chronic Liver Disease 58 Reduces Mortality 58 Hip Fracture Risk 58 Pressure Ulcers 58 Bone Metastases 58 Related Mortality 58 Peripheral Artery Disease 58 Ischaemic 58 Improve Diagnosis 58 Sustained Reduction 58 Randomized Trials 58 REVEAL Registry 58 Chronic Renal Failure 58 Diabetic Macular Edema 58 Breast Tissue 58 Allogeneic 58 Ischemia 58 Childhood Immunizations 58 Unstable Angina 58 Kidney Failure 57 Diabetic Nephropathy 57 Colorectal Cancer Screening 57 ischemic complications 57 Postmenopausal Women 57 Blood Pressure Monitoring 57 Atopic Dermatitis 57 deep venous thromboses 57 Serious Adverse Events 57 Renal Transplantation 57 Breast Tumor 57 Coronary Revascularization 57 Lupus Nephritis 57 Critical Limb Ischemia CLI 57 Gestational Diabetes 57 Bacteremia 57 Differential Diagnosis 57 Shows Promise Against 57 Crit Rev 57 Pivotal Trial 57 Hyperparathyroidism 57 Fabry Disease 57 HPV Vaccine Gardasil 57 Viral Suppression 57 Bipolar Depression 57 Genetic Markers 57 Implantable Cardioverter Defibrillators 57 Paroxysmal Atrial Fibrillation 57 Subarachnoid hemorrhage 57 Experimental Vaccine 57 Autologous Stem Cell Transplantation 57 Knee Arthritis 57 Pooled Analysis 57 Proteinuria 57 unstable angina pectoris 57 Comorbidities 57 Randomized Clinical Trial 57 Antiepileptic Drug 57 Gene Mutations 57 Stress Induced 57 Congestive Heart Failure 57 Total Hip Replacement 57 Coronary Artery Disease 57 Liver Damage 57 Morbid Obesity 57 Seasonal Influenza Vaccine 57 Demonstrated Significant 57 Study Shows Significant 57 Phase Ib Clinical Trial 57 Refractory Angina 57 Therapy Reduces 57 Therapy Shows Promise 57 Allergic Conjunctivitis 57 Cardiometabolic 57 Gum Disease 57 Ophthalmic Surgery 57 Systemic Lupus Erythematosus SLE 57 Therapeutic Effects 57 Autoimmune Disease 57 Tiotropium 57 Clinical Decision Making 57 Muscle Function 57 Functional Outcomes 57 Relapsing Remitting Multiple Sclerosis 57 SUBSIDIARIES SELECTED FINANCIAL DATA 57 Renal Cell Carcinoma RCC 57 Strongly Linked 57 Significant Improvements 57 Ovary Removal 57 HDL Cholesterol 57 Myocardial Infarction 57 Insulin Delivery 57 Endocrine Therapy 57 Investigational Treatment 57 Contrast Induced Nephropathy 57 Breast Cancer Metastasis 57 Resistant Hypertension 57 Reduces Risk 57 Prognostic Factors 57 Renal Tumors 57 Bone Marrow Transplants 57 Diabetic Retinopathy 57 Dietary Fat 57 Muscle Wasting 57 Rhinosinusitis 57 Stroke Risk 57 Hyperkalemia 57 Risk Stratification 57 Fibrosis 57 Malignant Melanoma 56 Parenteral Nutrition 56 Male Fertility 56 Left Ventricular Dysfunction 56 ARIXTRA R 56 Bronchiectasis 56 Environ Health Perspect 56 Genes Predict 56 Estrogen deficiency 56 Thrombocytopenia 56 Lupus Drug 56 Maternal Deaths 56 Gene Linked 56 Chronic Lyme Disease 56 Newly Diagnosed Multiple Myeloma 56 Excessive Sweating 56 Ovarian Cancer Risk 56 Aortic Aneurysms 56 Better Outcomes 56 Stem Cell Transplants 56 Coronary Artery Bypass Grafting 56 Showed Significant 56 Hemodialysis Patients 56 Nonalcoholic Steatohepatitis 56 Aromatase Inhibitors 56 Osteoporosis Drugs 56 Antiviral Therapy 56 Pivotal Study 56 Premature Birth 56 Genital Warts 56 Growth Trajectory 56 Exacerbation 56 Improve Patient Safety 56 ICAEL 56 Chronic Kidney Disease 56 Erythropoietic therapies may 56 Eluting Stent 56 Brain Aneurysms 56 Androgen Deprivation Therapy 56 Colorectal Screening 56 Childhood Asthma 56 #:# -# [004] 56 Aggressive Reduction 56 variceal bleeding 56 Study Shows Benefits 56 Clinically Significant 56 Patient Registry 56 Migraine Headaches 56 Double Blind Randomized 56 Endometrial Cancer 56 Liver Fibrosis 56 Patient Centered 56 Anticoagulant 56 Preclinical Models 56 RE LY ® 56 Myocardial Perfusion Imaging 56 Improving Patient 56 Chronic Wounds 56 Iodine Deficiency 56 AA Amyloidosis 56 Acne Drug 56 Aggressive Prostate Cancer 56 Systematic Review 56 Screening Mammography 56 Osteoporosis Treatment 56 Renal dysfunction 56 Malignancies 56 Arch Intern Med 56 Novel Therapies 56 Follicular Lymphoma 56 Blood Clots 56 Meningococcal Disease 56 Chronic HCV 56 Preclinical Study 56 Cataract Surgery 56 Advanced Renal Cell 56 Protein Involved 56 Breast Cancers 56 antithrombotic therapies 56 Inflammatory Disease 56 Improving Patient Care 56 Pediatric Asthma 56 Mucositis 56 Progenitor Cells 56 Predict Risk 56 Prenatal Diagnosis 56 Ischemic Heart Disease 56 Aortic Aneurysm 56 Antidepressant Use 56 Acute Renal Failure 56 Cardiovascular Mortality 56 Colorectal Adenomas 56 Low Incidence 56 Slow Progression 56 Suicidality 56 Current Controlled Trials 56 Randomized Study 56 Demonstrate Significant 56 Uterine Fibroid 56 Circulatory Support 56 Heart Failure Treatment 56 Arch Neurol 56 ARIXTRA 56 Study Evaluates 56 Improve Patient 56 Colorectal 56 Retinal Vein Occlusion 56 J Clin Endocrinol Metab 56 Viral Infection 56 Male Infertility 56 Endothelial Function 56 Premature Babies 56 Acute Liver Failure 56 Preventive Care 56 Genetic Variation 56 Significant Reduction 56 Colorectal Cancer Risk 56 Study Evaluating 56 Remote Patient Monitoring 56 Asthma Attacks 56 Glucose Monitoring 56 Smallpox Vaccination 56 Demonstrates Statistically Significant 56 Cholesterol Screening 56 PRODUCT SALES 56 Treatment Outcomes 56 Osteoporotic 56 Musculo Skeletal Disorders 56 Medication Error 55 Multicenter Study 55 See ID nBMB# 55 Vertebral Compression Fractures 55 Prostate Surgery 55 Helps Predict 55 Ovarian Cancers 55 Phase 2a Trial 55 Chronic Cough 55 Unresectable 55 Hepatitis C Infection 55 Benign Prostatic Hyperplasia 55 Newly Diagnosed 55 Hypertriglyceridemia 55 Immunogenicity 55 morbidity mortality 55 Wound Closure 55 Glucose Metabolism 55 Genetic Testing 55 Thyroid Problems 55 postoperative atrial fibrillation 55 Study Reinforces 55 Candesartan 55 Diabetes Epidemic 55 Chronic Insomnia 55 Dialysis Outcomes 55 Chemotherapeutic Agents 55 Diagnostic Tests 55 Breast Cancer Treatment 55 DVT PE 55 Mechanical Ventilation 55 ADHD Medication 55 Achieve Meaningful Use 55 Gets FDA Clearance 55 Correlation Between 55 Brain Aneurysm 55 Diabetic Foot Ulcer 55 prospective multicenter study 55 Neuroendocrine Tumor 55 STRATEGY FOR AN OPEN 55 Immune Mediated 55 Inflammatory Arthritis 55 Effective Treatments 55 Cancer Treatments 55 FDA Approves Drug 55 FASEB J. 55 Blood Glucose 55 Inhaled Liposomal Ciprofloxacin 55 Gastric Bypass Surgery 55 Adenomas 55 Demonstrates Ability 55 Beta Blocker 55 Late Breaker 55 ACCF AHA 55 Breast Exams 55 intracranial hemorrhage ICH 55 Short Stature 55 Prenatal Screening 55 Solid Tumors 55 Non Melanoma Skin 55 Watchful Waiting 55 Decitabine 55 See ID nBOM# [001] 55 Venous thromboembolism 55 hypercholesterolaemia 55 Hematological 55 Bacterial Infections 55 Fatty Liver 55 Immunologic 55 Eye Diseases 55 Carotid Artery Stenting 55 metastatic neuroendocrine tumors 55 Calcium Supplements 55 Pneumococcal Disease 55 Hormone Therapy 55 Prostate Cancer Recurrence 55 #:# -# [005] 55 Study Demonstrates 55 Phase III Clinical Trials 55 Significantly Reduces 55 Cardiovascular Risk Reduction 55 Hormonal Contraceptives 55 Atypical Hemolytic Uremic Syndrome 55 Neoplasms 55 Shows Efficacy 55 Clinical Practice Guideline 55 #:# -# [003] 55 Nicotine Addiction 55 Cognitive Function 55 Rheumatoid 55 Patient Focused 55 Bleeding Disorder 55 Teva Provides Update 55 ID nTKU# 55 leiomyomas 55 Ann Emerg Med 55 ACE Inhibitors 55 Immunodeficiency 55 Perindopril 55 HF hospitalization 55 Diagnostic Tools 55 cerebral vasospasm 55 Benazepril 55 Hepatitis C Virus 55 Therapy Evaluation 55 J Pediatr 55 Cluster Headaches 55 R lenalidomide 55 neonatal morbidity 55 Growth Hormone Deficiency 55 serum phosphate 55 Neoplasia 55 Antiretroviral Therapy 55 Non Alcoholic Steatohepatitis 55 Hematological Cancers 55 ARCOXIA 55 Pre Eclampsia 55 Therapeutic Intervention 55 bacterial prostatitis 55 Cholesterol Levels SPARCL 55 #:#-# [007] 55 Chronic Hepatitis C 55 Novel Approaches 55 Obstructive Sleep Apnea 55 Prediabetes 55 perioperative mortality 55 Sinus Infections 55 Loss Ratios 55 Erythropoietic 55 Improve Patient Outcomes 55 SEROQUEL R 55 Perinatal Mortality 55 XIENCE V PROMUS Stent 55 Carotid Endarterectomy 55 Venous Thromboembolism VTE 55 upper gastrointestinal bleeding 55 Dendritic Cells 54 Insulin Resistance 54 Urinary Tract Infection 54 Pregnancy Complications 54 Genetic Basis 54 Genetic Variations 54 Readmission 54 Congenital Heart Defects 54 Registry NOPR 54 Peripheral Arterial Disease 54 Alternative Treatments 54 ADHF 54 Genetic Variant 54 Vascular Disease 54 Antiretroviral Drug 54 MMR Vaccine 54 Pregnancy Registry 54 Demonstrates Sustained 54 Improving Efficiency 54 Malignant Glioma 54 Prostate Biopsy 54 Rotavirus Vaccines 54 Peripheral Blood 54 Polypharmacy 54 hyperphenylalaninemia HPA due 54 Prevalence Estimates 54 thromboembolic 54 Shingles Vaccine 54 National Oncologic PET 54 Arch Dis Child 54 nephrotoxicity 54 Cerebril TM 54 Lung Cancer Screening 54 Nesiritide 54 Cell Transplant 54 Vaccine Protects Against 54 Hosp Epidemiol 54 Lowering Cholesterol 54 Cognitive Decline 54 MANAGEMENT DISCUSSION AND ANALYSIS 54 Retinopathy 54 Kidney Disease Outcomes 54 DAS# Fludase ® 54 Migraine Sufferers 54 NPS Pharmaceuticals Announces 54 oral FTY# 54 Immunotherapeutic 54 Stem Cell Transplant 54 Musculoskeletal Diseases 54 Patient Throughput 54 invasive aspergillosis 54 MYCAMINE 54 Postherpetic Neuralgia 54 Often Misdiagnosed 54 Urine Test 54 Chronic Rhinosinusitis 54 ONTARGET 54 Patient Recruitment 54 HER2 Positive 54 Cardiorespiratory 54 Restanza TM 54 Biomarker Study 54 Diabetic Peripheral Neuropathy 54 glucocorticoid therapy 54 Risedronate 54 II Clinical Trial 54 Contrast Enhanced 54 heparin induced thrombocytopenia 54 Breast Cancer Risk 54 pancytopenia 54 Hospitalizations 54 Vaccine Candidate 54 Renal Disease 54 Combination REOLYSIN R 54 Metastatic Melanoma 54 TAXUS ATLAS 54 Zenvia Phase III 54 lucinactant 54 Medication Reconciliation 54 ID NCT# 54 Pressure Monitoring 54 Operating Efficiencies 54 Prostate Cancer Outcomes 54 Catheterization 54 macrovascular events 54 Helps Smokers Quit 54 Chronic Obstructive Lung 54 Lymphocytic 54 Prehypertension 54 Childhood Leukemia 54 Dyspnea 54 Pulmonary Embolism PE 54 Systemic Sclerosis 54 Balance Sheet Restructuring 54 Comorbid 54 Lumbar Spine 54 Asymptomatic 54 Respiratory Illness 54 Enlarged Prostate 54 Strengthen Balance Sheet 54 invasive candidiasis 54 number NCT# ClinicalTrials.gov 54 Coronary Heart Disease 54 nonfatal myocardial infarction MI 54 Diabetic Eye 54 Chronic Myeloid Leukemia 54 Diabetic Foot Care 54 Early Diagnosis 54 ATACAND 54 Bone Density 54 Structural Changes 54 BioSante Pharmaceuticals Reports 54 Genetic Defect 54 Hemophilia B 54 Cost Effectiveness 54 ARCALYST ® rilonacept 54 Hyperglycemia 54 Edge STudy 54 Trend Toward 54 Improved Outcomes 54 Gluten Intolerance 54 Heart Failure Trial 54 Prophylaxis 54 Successful Implementation 54 Double Blind Placebo 54 atherothrombotic 54 Lymphoid 54 Am Soc Nephrol 54 Upward Revision 54 Clinical Guideline 54 External Defibrillators 54 Medication Compliance 54 Novel Oral 54 Dyslipidemia 54 Vitamin D Supplementation 54 pancreatectomy 54 mg BID dose 53 Thyroid Hormone 53 Stakeholder Insight 53 J Nutr 53 Cardiac Arrhythmias 53 Female Urology 53 Oxidized LDL 53 Sepsis 53 Pivotal Phase 53 Calcium Vitamin D 53 Drug Approvals 53 Capsule Endoscopy 53 Gene Mutation Linked 53 simplex virus 53 Atherosclerotic 53 C Reactive Protein 53 Benign Prostatic Hyperplasia BPH 53 Diamyd Medical Diamyd 53 Disease Outbreaks 53 OR Live.com Presents 53 Supply Chain Efficiencies 53 Preclinical Efficacy 53 CLABSIs 53 Islet Transplantation 53 Acute Stroke 53 APTIVUS 53 Underscore Need 53 Randomized Double blind 53 ACE Inhibitor 53 Randomized Controlled 53 #:#-# [023] 53 Blepharospasm 53 Diagnosis Treatment 53 Services #:#-#,# Abstract 53 Controlled Study 53 Interstitial Cystitis 53 Spectranetics laser 53 hepatic cirrhosis 53 cholestasis 53 Coronary artery bypass grafting 53 Seasonal Influenza 53 Innovative Approaches 53 Menopausal Symptoms 53 Crit Care 53 Post Menopausal 53 Quantifiable 53 Antihypertensive 53 LIFELONG HEALTH 53 abstr 53 Postnatal Depression 53 Pemphigus 53 Treatment Adherence 53 Radiation Treatment 53 Warfarin Coumadin 53 Adjuvant Breast Cancer 53 dyslipidaemia 53 Clinical Practice Guidelines 53 antiphospholipid syndrome 53 complement inhibitor eculizumab 53 Radioimmunotherapy 53 Periodontitis 53 NOMID 53 Trigeminal Neuralgia 53 Gender Specific 53 Metastatic Cancer 53 Gynecol Oncol 53 Protein Expression 53 Arthritis Musculoskeletal 53 Patient Adherence 53 Myocardial Perfusion 53 Cognitive Deficits 53 Pre eclampsia 53 Subprime Concern 53 Efficacy Trial 53 Antiepileptic Drugs 53 Biologic Drugs 53 Improves Patient 53 NCQA Certification 53 Adolescent Depression 53 Hypoglycemia 53 Systolic Hypertension 53 Cerebral Aneurysms 53 Infusion Systems 53 FINANCIAL RESOURCES 53 Prevent Deep Vein 53 hemodilution 53 immunocompromised patients 53 Progressive Multifocal Leukoencephalopathy 53 Payer Forum 53 Prolongs Life 53 PROactive 53 antithrombotic therapy 53 PROSTASCINT R 53 Haemorrhage 53 Acute Pancreatitis 53 ID TLR 53 Intracerebral 53 infective endocarditis 53 Significant Improvement 53 acute PAO 53 Trend Towards 53 Therapeutic Advances 53 myopathy rhabdomyolysis 53 Pulmonary Hypertension 53 Major Depressive Disorder 53 recurrent glioma 53 Cardiovascular Risk 53 Whole Genome Sequencing 53 Ankylosing Spondylitis 53 Leukemias 53 Cardio vascular 53 osteoporotic vertebral fractures 53 mixed hyperlipidemia 53 EGFR HER2 53 Injectable Drug 53 Alcohol Consumption 53 Antipsychotic Drugs 53 Hsp# Inhibitor 53 Postmenopausal 53 myocardial infarction ventricular fibrillation 53 Mammography Screening 53 Osteoporosis Screening 53 Package Insert 53 Dollar Holds Steady 53 HBeAg + 53 NATRECOR ® 53 Metabolic Disease 53 Clotting 53 debilitating complication 53 Aethlon Medical Releases 53 Rheumatic Fever 53 Arterial Disease 53 Hospitalisation 53 Peripheral arterial disease 53 EVEREST II 53 Ad5FGF 4 53 atrophic gastritis 53 Mechanical Circulatory Support 53 Cytomegalovirus CMV 53 LHON 53 Breast Ovarian Cancer 53 Ventricular Tachycardia 53 Moxifloxacin 53 HIV HCV coinfected 53 Multicenter Phase 53 Cardiopulmonary bypass 53 Vulvar 52 Prevent Fractures 52 ASMBS 52 Vascugel ® 52 Depressive Disorders 52 Patient Centric 52 Inflammatory Pain 52 CMV infection 52 Ear Infections 52 Observational Studies 52 Male Contraceptive 52 NYSE Amex Listing 52 von Willebrand Disease 52 dyspnea pulmonary infiltrates pneumonitis 52 Topline Results 52 Mln Share Buyback 52 Psychiatric Disorders 52 ASBMR 52 postoperative mortality 52 Immunosuppressant 52 liver transplantations 52 Child Mortality 52 Artificial Pancreas 52 Clinical Remission 52 Analytical Tool 52 Main Outcome Measure 52 Choppy Trading 52 Bipolar Disorders 52 Pressure Ulcer 52 Clostridium Difficile Associated 52 symptomatic intracranial 52 Smoking Cessation Programs 52 TG MV 52 Neurodegenerative